1 / 6

Global Oncology Biosimilars Market Forecast 2014-2018

Research analysts forecast the Global Oncology Biosimilars market to grow at a CAGR of 29.87 percent over the period 2013-2018. Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of the original biological medicines.

cassiar321
Télécharger la présentation

Global Oncology Biosimilars Market Forecast 2014-2018

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Oncology Biosimilars Market 2014-2018 (Type, Mode of action, Crop Type and Geography) - Size, Share, Global and China Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 • TELEPHONE: +1 (855) 711-1555E-MAIL: help@researchbeam.com Published on : Oct 2015

  2. Report Overview Report Overview : About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of the original biological medicines. Though biosimilars have many similarities to the innovator product, they are not an exact copy of the reference biopharmaceutical product. Currently, biosimilars are being incorporated into oncology treatment practices. The biosimilars used in oncology in the supportive care setting are known as oncology biosimilars. Research analysts forecast the Global Oncology Biosimilars market to grow at a CAGR of 29.87 percent over the period 2013-2018. Covered in this Report : This report covers the present scenario and the growth prospects of the Global Oncology Biosimilars market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales biosimilars used in cancer treatment. Research report, Global Oncology Biosimilars Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions.

  3. Report Overview it also covers the Global Oncology Biosimilars market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Regions • Americas • APAC • EMEA Key Vendors • Biocon • Celltrion • Dr. Reddy's Laboratories • Hospira Other Prominent Vendors • 3SBio • Abbvie • AstraZeneca For More Information Read Full Report With TOC @ http://www.researchbeam.com/global-oncology-biosimilars-2014-2018-market

  4. Report Overview Market Driver • Increased Number of Patent Expirations Market Challenge • Risks Related to Drug Failure Market Trend • Outsourcing of Biosimilar Manufacturing Key Questions Answered in this Report • What will the market size be in 2018 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?

  5. Table Of Contents: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Introduction 06. Market Landscape 06.1 Market Overview 06.2 Market Size and Forecast 06.3 Five Forces Analysis 07. Segmentation by Application 07.1 Cancer Treatment Drugs 07.2 Supportive Care Drugs 08. Geographical Segmentation Enquire About Report : http://www.researchbeam.com/global-oncology-biosimilars-2014-2018-market/enquire-about-report

  6. FOR MORE DETAILS Visit us at : www.researchbeam.com/global-oncology-biosimilars-2014-2018-market Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com

More Related